HECW2-AS1
gene geneOn this page
Summary
HECW2-AS1 (HECW2 antisense RNA 1, HGNC:54062) is a long non-coding RNA gene on chromosome 2q32.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:54062 |
| Approved symbol | HECW2-AS1 |
| Name | HECW2 antisense RNA 1 |
| Location | 2q32.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000229056 |
| Ensembl biotype | lncRNA |
| Entrez | 101927482 |
| RNAcentral | URS000075D97D — lncRNA, 1424 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000430904, ENST00000433933, ENST00000605907, ENST00000748258
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000430904 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001749456 | 196260331 | 196260372 |
| ENSE00004090884 | 196263051 | 196264204 |
| ENSE00004090885 | 196260019 | 196260240 |
Expression profiles
Bgee: expression breadth ubiquitous, 143 present calls, max score 80.32.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8601 / max 788.4400, expressed in 287 samples.
FANTOM5 promoters (13 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 24449 | 0.4584 | 92 |
| 24452 | 0.3804 | 63 |
| 24448 | 0.3404 | 85 |
| 24447 | 0.1832 | 65 |
| 24451 | 0.1232 | 34 |
| 24446 | 0.1225 | 45 |
| 24454 | 0.0795 | 5 |
| 24455 | 0.0626 | 19 |
| 24453 | 0.0455 | 11 |
| 24458 | 0.0245 | 6 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 80.32 | gold quality |
| prostate gland | UBERON:0002367 | 78.67 | gold quality |
| bone marrow cell | CL:0002092 | 73.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.00 | gold quality |
| leukocyte | CL:0000738 | 70.90 | gold quality |
| monocyte | CL:0000576 | 70.61 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.59 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 70.02 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.47 | gold quality |
| lymph node | UBERON:0000029 | 69.46 | gold quality |
| granulocyte | CL:0000094 | 69.33 | gold quality |
| placenta | UBERON:0001987 | 69.18 | gold quality |
| rectum | UBERON:0001052 | 69.17 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 69.11 | gold quality |
| gall bladder | UBERON:0002110 | 68.99 | gold quality |
| adrenal cortex | UBERON:0001235 | 67.20 | gold quality |
| jejunal mucosa | UBERON:0000399 | 67.19 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.84 | gold quality |
| adrenal gland | UBERON:0002369 | 66.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 65.44 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 65.27 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 64.31 | gold quality |
| ventricular zone | UBERON:0003053 | 64.09 | gold quality |
| small intestine | UBERON:0002108 | 63.76 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.18 | gold quality |
| caecum | UBERON:0001153 | 59.97 | gold quality |
| blood | UBERON:0000178 | 57.14 | gold quality |
| ileal mucosa | UBERON:0000331 | 57.13 | gold quality |
| islet of Langerhans | UBERON:0000006 | 56.86 | gold quality |
| calcaneal tendon | UBERON:0003701 | 56.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.52 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.